United Therapeutics | UTHR - Current Assets



United Therapeutics reported $3.83B in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
Amarin USD 573.06M 22.34M Mar/2025
Ardelyx USD 351.57M 4.88M Jun/2025
Baxter International USD 7.04B 1.82B Mar/2025
Bayer EUR 33.75B 1.08B Jun/2025
Biogen USD 7.97B 341.7M Jun/2025
BioMarin Pharmaceutical USD 3.81B 337.43M Jun/2025
Gilead Sciences USD 14.72B 2.18B Jun/2025
GlaxoSmithKline GBP 17.67B 412M Jun/2025
Halozyme Therapeutics USD 1.12B 139.35M Jun/2025
Insmed USD 2.08B 678.89M Jun/2025
Ionis Pharmaceuticals USD 2.58B 158.22M Jun/2025
J&J USD 71.55B 15.66B Mar/2025
Moderna USD 6.17B 595M Jun/2025
Pfizer USD 43.7B 2.16B Jun/2025
PTC Therapeutics USD 2.27B 43.53M Jun/2025
Regeneron Pharmaceuticals USD 16.86B 712.2M Jun/2025
Sarepta Therapeutics USD 2.66B 224.45M Jun/2025
Teva Pharmaceutical Industries USD 12.62B 1.09B Jun/2025
United Therapeutics USD 3.83B 112.9M Jun/2025
Vertex Pharmaceuticals USD 10.43B 419.1M Jun/2025